“Our collaboration with Dicerna to discover and develop GalXC RNAi therapies, which have the potential to inhibit uncontrolled activation of the complement system in new ways, represents an exciting ...
STARKVILLE, Miss.—Protection of personal healthcare information is a well-established right for patients, and technology underpins almost every aspect of healthcare operations. A recent cyber tabletop ...
RESEARCH TRIANGLE PARK, N.C., Sept. 30, 2015 /PRNewswire/ -- Liquidia Technologies today announced that GlaxoSmithKline (GSK) has exercised its option under a Collaboration and Option Agreement signed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback